Down Syndrome Metabolic Health Study

CompletedOBSERVATIONAL
Enrollment

257

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

August 25, 2017

Study Completion Date

August 25, 2017

Conditions
Down SyndromeTrisomy 21
Trial Locations (2)

19104

The Children's Hospital of Philadelphia, Philadelphia

20010

Children's National Medical Center, Washington D.C.

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Children's Hospital of Philadelphia

OTHER

NCT01821300 - Down Syndrome Metabolic Health Study | Biotech Hunter | Biotech Hunter